Publikationen

Karsten Dafonte K., Lutz P., Jansen C., Busse M., Dietrich P., Farker K., Lipp HP., Nattermann J., Sauerbruch T., Schmiedl S., Strobach D., Trebicka J., Zocholl D., Hartmann G., Jaehde U., Coenen M.:
Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert Panel
In: Clinical Drug Investigation 46 (2026), p. 377-390
ISSN: 1173-2563
DOI: 10.1007/s40261-026-01536-0

Mutlu MY., Kleyer A., Krönke G., Fagni F., Temiz A., Meder C., Dietrich P., Orlemann T., Mößner J., Schönau V., Bohr D., Schuster L., Hartmann F., Minopoulou I., Leppkes M., Ramming A., Pachowsky M., Schuch F., Ronneberger M., Kleinert S., Hueber A., Manger K., Manger B., Atreya R., Berking C., Sticherling M., Neurath M., Schett G., Simon D., Tascilar K.:
Paucity of viral infection symptoms in patients with immune-mediated inflammatory diseases.
In: BMJ Open 15 (2025)
ISSN: 2044-6055
DOI: 10.1136/bmjopen-2024-088486
Plechschmidt J., Fietkau K., Hepp T., Dietrich P., Fischer S., Krebs S., Neurath M., Dörje F., Atreya R.:
Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial.
In: Inflammatory Bowel Diseases 31 (2025), p. 77-86
ISSN: 1078-0998
DOI: 10.1093/ibd/izae040
Roth D., Düll M., Horst LJ., Lindemann A., Malzer X., Koop K., Zundler S., Vetter M., Jefremow A., Atreya R., Geppert CI., Weidemann S., Waldner M., Dietrich P., Günther C., Munoz LE., Herrmann M., Scheffold A., Neurath M., Siebler J., Schramm C., Kremer A., Leppkes M.:
Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
In: Journal of Crohns & Colitis 19 (2025), Article No.: jjae131
ISSN: 1873-9946
DOI: 10.1093/ecco-jcc/jjae131
Wormser L., Fritz V., Kappelmann-Fenzl M., Rachinger N., Escudé P., Enderle K., Kaufmann M., Düll M., Mahli A., Zundler S., Leppkes M., Fischer S., Elsner F., Geppert CI., Hannus M., Merkel S., Erdmann M., Günther C., Evert K., El Ahmad Z., Meister G., D'Avanzo E., Stemmler M., Neufert C., Kremer AE., Weber GF., Brabletz T., von Hörsten S., Wiest R., Schiffelers R., Hartmann A., Siebler J., Trebicka J., Waldner M., Neurath M., Hellerbrand C., Boßerhoff AK., Dietrich P.:
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche
In: Proceedings of the National Academy of Sciences of the United States of America 122 (2025), p. e2518418122
ISSN: 0027-8424
DOI: 10.1073/pnas.2518418122

Dorner H., Stolzer I., Mattner J., Kaminski S., Leistl S., Edrich LM., Schwendner R., Hobauer J., Sebald ATE., Leikam S., Gonzalez Acera M., Düll M., Lang R., Seidel G., Seitz T., Hellerbrand C., Fuhrmann G., Distler U., Tenzer S., Eichhorn P., Vieth M., Schramm C., Arnold P., Becker C., Weidinger C., Siegmund B., Atreya R., Leppkes M., Naschberger E., Sampaziotis F., Dietrich P., Rauh M., Wirtz S., Kremer A., Neurath M., Günther C.:
Gut Pathobiont–Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis–Associated Inflammatory Bowel Disease
In: Gastroenterology (2024)
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2024.06.032
Fischer S., Donhauser M., Cohnen SE., Fietkau K., Vetter M., Grübel-Liehr M., Dietrich P., Rath T., Wilfer A., Sologub L., Krebs S., Dörje F., Nagore D., Meyer S., Neurath M., Atreya R.:
Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study
In: Therapeutic Advances in Gastroenterology 17 (2024)
ISSN: 1756-283X
DOI: 10.1177/17562848241301887

Ortiz C., Klein S., Reul WH., Magdaleno F., Groeschl S., Dietrich P., Schierwagen R., Uschner FE., Torres S., Hieber C., Meier C., Kraus N., Tyc O., Brol M., Zeuzem S., Welsch C., Poglitsch M., Hellerbrand C., Alfonso-Prieto M., Mira F., Keller UAD., Tetzner A., Moore A., Walther T., Trebicka J.:
Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1
In: Cell Reports 42 (2023)
ISSN: 2211-1247
DOI: 10.1016/j.celrep.2023.112059
Payani E., Börner N., Kolliogiannis D., Brunner S., Klein I., Ehmer U., Denk G., Lange CM., Ograja K., Dietrich P., Werner J., Guba M.:
Regional transplant rates depend more on physician-dependent variables than on proximity to transplant center
In: Langenbecks Archives of Surgery 408 (2023), Article No.: 191
ISSN: 1435-2443
DOI: 10.1007/s00423-023-02874-9
Sommer J., Ehnis H., Seitz T., Schneider J., Wild A., Moceri S., Buechler C., Bozec A., Weber G., Merkel S., Beckervordersandforth R., Steinkasserer A., Schüle R., Trebicka J., Hartmann A., Boßerhoff AK., von Hörsten S., Dietrich P., Hellerbrand C.:
Four-and-a-Half LIM-Domain Protein 2 (FHL2) Induces Neuropeptide Y (NPY) in Macrophages in Visceral Adipose Tissue and Promotes Diet-Induced Obesity
In: International Journal of Molecular Sciences 24 (2023), Article No.: 14943
ISSN: 1422-0067
DOI: 10.3390/ijms241914943

Düll M., Karlen V., Vetter M., Dietrich P., Kupfer J., Neurath M., Kremer A.:
Chronic pruritus represents a major burden in non-cholestatic hepatobiliary disorders
In: JOURNAL OF HEPATOLOGY, AMSTERDAM: 2022
DOI: 10.1016/s0168-8278(22)00705-x
Seitz T., John N., Sommer J., Dietrich P., Thasler WE., Hartmann A., Evert K., Lang SA., Boßerhoff AK., Hellerbrand C.:
Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche
In: International Journal of Molecular Sciences 23 (2022), Article No.: 11524
ISSN: 1422-0067
DOI: 10.3390/ijms231911524
Simon D., Tascilar K., Fagni F., Kleyer A., Krönke G., Meder C., Dietrich P., Orlemann T., Mößner J., Taubmann J., Mutlu MY., Knitza J., Kemenes S., Liphardt AM., Schönau V., Bohr D., Schuster L., Minopoulou I., Leppkes M., Ramming A., Pachowsky M., Schuch F., Ronneberger M., Kleinert S., Hueber A., Manger K., Manger B., Atreya R., Berking C., Sticherling M., Neurath M., Schett G., Hartmann F.:
Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study.
In: The Lancet Rheumatology 4 (2022), p. e614-e625
ISSN: 2665-9913
DOI: 10.1016/S2665-9913(22)00191-6
Simon D., Tascilar K., Kleyer A., Fagni F., Krönke G., Meder C., Dietrich P., Orlemann T., Kliem T., Moessner J., Liphardt AM., Schönau V., Bohr D., Schuster L., Hartmann F., Leppkes M., Ramming A., Pachowsky M., Schuch F., Ronneberger M., Kleinert S., Hueber A., Manger K., Manger B., Atreya R., Berking C., Sticherling M., Neurath M., Schett G.:
Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort
In: Arthritis and Rheumatology (2022)
ISSN: 2326-5191
DOI: 10.1002/art.42035
Tascilar K., Simon D., Kleyer A., Fagni F., Krönke G., Meder C., Dietrich P., Orlemann T., Kliem T., Moessner J., Liphardt AM., Schönau V., Bohr D., Schuster L., Hartmann F., Taubmann J., Leppkes M., Ramming A., Pachowsky M., Schuch F., Ronneberger M., Kleinert S., Hueber A., Manger K., Manger B., Atreya R., Berking C., Sticherling M., Neurath M., Schett G.:
LONG-TERM HUMORAL RESPONSE TO SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASE
In: ANNALS OF THE RHEUMATIC DISEASES, LONDON: 2022
DOI: 10.1136/annrheumdis-2022-eular.5079

Düll M., Wolf K., Vetter M., Dietrich P., Neurath M., Kremer A.:
Endogenous Opioid Levels Do Not Correlate With Itch Intensity and Therapeutic Interventions in Hepatic Pruritus
In: Frontiers in Medicine 8 (2021), Article No.: 641163
ISSN: 2296-858X
DOI: 10.3389/fmed.2021.641163
Fritz V., Malek L., Gaza A., Wormser L., Appel M., Kremer A., Thasler WE., Neurath M., Hellerbrand C., Boßerhoff AK., Dietrich P., Siebler J.:
Combined de‐repression of chemoresistance associated mitogen‐activated protein kinase 14 and activating transcription factor 2 by loss of microrna‐622 in hepatocellular carcinoma
In: Cancers 13 (2021), p. 1-14
ISSN: 2072-6694
DOI: 10.3390/cancers13051183
Gaza A., Fritz V., Malek L., Wormser L., Treiber N., Danner J., Kremer AE., Thasler WE., Siebler J., Meister G., Neurath MF., Hellerbrand C., Boßerhoff AK., Dietrich P.:
Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11
In: Neoplasia 23 (2021), p. 502-514
ISSN: 1522-8002
DOI: 10.1016/j.neo.2021.04.001
Seitz T., Hackl C., Freese K., Dietrich P., Mahli A., Thasler RM., Thasler WE., Lang SA., Boßerhoff AK., Hellerbrand C.:
Xanthohumol, a prenylated chalcone derived from hops, inhibits growth and metastasis of melanoma cells
In: Cancers 13 (2021), p. 1-12
ISSN: 2072-6694
DOI: 10.3390/cancers13030511
Vetter M., Dietrich P., Kremer A.:
Therapy adaption by dose titration of obeticholic acid in a 57-year-old female patient with PBC and advanced liver fibrosis
In: SWISS MEDICAL WEEKLY, MUTTENZ: 2021
Weindl L., Atreya I., Dietrich P., Neubeck S., Neurath M., Pavel ME.:
Targeted inhibition of the WEE1 kinase as a novel therapeutic strategy in neuroendocrine neoplasms
In: Endocrine-Related Cancer 28 (2021), p. 605-620
ISSN: 1351-0088
DOI: 10.1530/ERC-20-0500

Dietrich P., Wormser L., Fritz V., Seitz T., de Maria M., Schambony A., Kremer A., Günther C., Itzel T., Thasler WE., Teufel A., Trebicka J., Hartmann A., Neurath M., von Hörsten S., Boßerhoff AK., Hellerbrand C.:
Molecular cross-talk between Y5-receptor and neuropeptide Y drives liver cancer
In: Journal of Clinical Investigation 130 (2020), p. 2509-2526
ISSN: 0021-9738
DOI: 10.1172/JCI131919
Jefremow A., Wiesmüller M., Rouse RA., Dietrich P., Kremer A., Waldner M., Neurath M., Siebler J.:
Beyond the border: The use of lenvatinib in advanced hepatocellular carcinoma after different treatment lines: A retrospective analysis
In: Journal of Physiology and Pharmacology 71 (2020), p. 717-728
ISSN: 0867-5910
DOI: 10.26402/jpp.2020.5.11
Jefremow A., Wiesmüller M., Rouse RA., Dietrich P., Kremer A., Waldner M., Neurath M., Siebler J.:
Efficiency and Toxicity of Lenvatinib in Advanced HCC in Later Treatment Lines
In: ONCOLOGY RESEARCH AND TREATMENT, BASEL: 2020
Koch A., Ebert EV., Seitz T., Dietrich P., Berneburg M., Boßerhoff AK., Hellerbrand C.:
Characterization of glycolysis-related gene expression in malignant melanoma
In: Pathology Research and Practice 216 (2020), Article No.: 152752
ISSN: 0344-0338
DOI: 10.1016/j.prp.2019.152752
Linck-Paulus L., Hellerbrand C., Boßerhoff AK., Dietrich P.:
Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma
In: Cells 9 (2020)
ISSN: 2073-4409
DOI: 10.3390/cells9010114
Schierwagen R., Dietrich P., Klein S., Uschner FE., Ortiz C., Tyc O., Torres S., Hellerbrand C., Sauerbruch T., Trebicka J.:
β-Arrestin2 is increased in liver fibrosis in humans and rodents
In: Proceedings of the National Academy of Sciences of the United States of America 117 (2020), p. 27082-27084
ISSN: 0027-8424
DOI: 10.1073/pnas.2014337117
Seitz T., Freese K., Dietrich P., Thasler WE., Boßerhoff AK., Hellerbrand C.:
Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma
In: Scientific Reports 10 (2020), Article No.: 4546
ISSN: 2045-2322
DOI: 10.1038/s41598-020-61510-4
Simon D., Tascilar K., Krönke G., Kleyer A., Zaiss M., Heppt F., Meder C., Atreya R., Klenske E., Dietrich P., Abdullah A., Kliem T., Corte G., Morf H., Leppkes M., Kremer A., Pachowsky M., Schuch F., Ronneberger M., Kleinert S., Meier C., Hueber A., Manger K., Manger B., Berking C., Tenbusch M., Überla K., Sticherling M., Neurath M., Schett G., Ramming A.:
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
In: Nature Communications 11 (2020), Article No.: 3774
ISSN: 2041-1723
DOI: 10.1038/s41467-020-17703-6
Simon D., Tascilar K., Krönke G., Kleyer A., Zaiss M., Heppt F., Meder C., Atreya R., Klenske E., Dietrich P., Abdullah A., Kliem T., Corte G., Morf H., Leppkes M., Kremer A., Ramming A., Pachowsky M., Schuch F., Ronneberger M., Kleinert S., Maier C., Hueber A., Manger K., Manger B., Berking C., Tenbusch M., Überla K., Sticherling M., Neurath M., Schett G.:
Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection
In: ARTHRITIS & RHEUMATOLOGY, HOBOKEN: 2020

Dietrich P., Gaza A., Wormser L., Fritz V., Hellerbrand C., Boßerhoff AK.:
Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma
In: Neoplasia 21 (2019), p. 257-268
ISSN: 1522-8002
DOI: 10.1016/j.neo.2018.11.011
Dietrich P., Hellerbrand C., Boßerhoff AK.:
The delta subunit of rod-specific photoreceptor cgmp phosphodiesterase (Pde6d) contributes to hepatocellular carcinoma progression
In: Cancers 11 (2019), Article No.: 398
ISSN: 2072-6694
DOI: 10.3390/cancers11030398
Freese K., Dietrich P., Boßerhoff AK., Hellerbrand C.:
Variation of different histone deacetylases and the functional effects of HDAC inhibitors in hepatocellular carcinoma
International Liver Congress (Vienna, 10. April 2019 - 14. April 2019)
In: JOURNAL OF HEPATOLOGY, AMSTERDAM: 2019
DOI: 10.1016/s0618-8278(19)30712-1
Freese K., Seitz T., Dietrich P., Lee SM., Thasler WE., Boßerhoff AK., Hellerbrand C.:
Histone deacetylase expressions in hepatocellular carcinoma and functional effects of histone deacetylase inhibitors on liver cancer cells in vitro
In: Cancers 11 (2019), Article No.: 1587
ISSN: 2072-6694
DOI: 10.3390/cancers11101587
Goeppert B., Truckenmueller F., Ori A., Fritz V., Albrecht T., Fraas A., Scherer D., Silos RG., Sticht C., Gretz N., Mehrabi A., Bewerunge-Hudler M., Pusch S., Bermejo JL., Dietrich P., Schirmacher P., Renner M., Roessler S.:
Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p
In: Scientific Reports 9 (2019)
ISSN: 2045-2322
DOI: 10.1038/s41598-019-40857-3
Mahli A., Seitz T., Beckroege T., Freese K., Thasler WE., Benkert M., Dietrich P., Weiskirchen R., Boßerhoff AK., Hellerbrand C.:
Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro
In: Cells 8 (2019)
ISSN: 2073-4409
DOI: 10.3390/cells8050457
Stieglitz D., Lamm S., Braig S., Feuerer L., Kuphal S., Dietrich P., Arndt S., Echtenacher B., Hellerbrand C., Karrer S., Boßerhoff AK.:
BMP6-induced modulation of the tumor micro-milieu
In: Oncogene 38 (2019), p. 609-621
ISSN: 0950-9232
DOI: 10.1038/s41388-018-0475-x

Riccardo Bertolo, Ithaar Derweesh, Giuseppe Simone, Michele Gallucci, Stephen Ryan, Ahmet Binday, Andrea Minervini, Marco Carini, Andrea Mari, Daniel Eun, Aryeh Keehn, Sisto Perdona, Giuseppe Quarto, James Porter, Michael Liao, Matteo Ferro, Alexandre Mottrie, Geert De Naeyer, Koon Rha, Kidon Chang, Robert Uzzo, Alexander Kutikov, David Chen, Marc Smaldone, Francesco Berardinelli, Luigi Schips, Wesley White, Bo Yang, Chao Zang, Ottavio De Cobelli, Ken Jacobsohn, Peter Langenstroer, Peter Dietrich, Prokar Dasgupta, Ben Challacombe, Nicolo De Luyk, Clayton Lau, Patrick Kilday, Jay Sulek, Chandru Sundaram, Francesco Montorsi, Alessandro Larcher, Umberto Capitanio, Inderbir Gill, Monish Aron, Akbar Ashrafi, Uzoma Anele, Lance Hampton, Gabriele Tuderti, Manuela Costantini, Riccardo Autorino, Francesco Porpiglia:
ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR CT2 RENAL TUMORS: PERIOPERATIVE, FUNCTIONAL AND ONCOLOGICAL OUTCOMES FROM A MULTICENTER ANALYSIS (THE ROSULA PROJECT)
Dietrich P., Freese K., Mahli A., Thasler WE., Hellerbrand C., Boßerhoff AK.:
Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option
In: Oncotarget 9 (2018), p. 3605-3618
ISSN: 1949-2553
DOI: 10.18632/oncotarget.23188
Dietrich P., Kuphal S., Spruss T., Hellerbrand C., Boßerhoff AK.:
MicroRNA-622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma
In: Pigment Cell & Melanoma Research (2018)
ISSN: 1755-1471
DOI: 10.1111/pcmr.12698
Schmidt KM., Dietrich P., Hackl C., Guenzle J., Bronsert P., Wagner C., Fichtner-Feigl S., Schlitt HJ., Geissler EK., Hellerbrand C., Lang SA.:
Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis
In: Neoplasia 20 (2018), p. 1198-1208
ISSN: 1522-8002
DOI: 10.1016/j.neo.2018.10.001

Dietrich P., Boßerhoff AK.:
Melanoma sponge on pigmentation gene to reduce tumour-suppressive microRNAs
In: Pigment Cell & Melanoma Research (2017)
ISSN: 1755-1471
DOI: 10.1111/pcmr.12660
Dietrich P., Koch A., Fritz V., Hartmann A., Boßerhoff AK., Hellerbrand C.:
Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance
In: Gut (2017)
ISSN: 0017-5749
DOI: 10.1136/gutjnl-2017-315402
Dietrich P., Kuphal S., Spruss T., Hellerbrand C., Boßerhoff AK.:
Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition
In: Oncogene (2017)
ISSN: 0950-9232
DOI: 10.1038/onc.2017.391
Mahli A., Saugspier M., Koch A., Sommer J., Dietrich P., Lee S., Thasler R., Schulze-Luehrmann J., Lührmann A., Thasler WE., Müller M., Boßerhoff AK., Hellerbrand C.:
ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis
In: Gut (2017)
ISSN: 0017-5749
DOI: 10.1136/gutjnl-2016-312485

Dietrich P., Boßerhoff AK.:
DNMT targets MiRacle torching TORCh
In: Pigment Cell & Melanoma Research 29 (2016), p. 399-401
ISSN: 1755-1471
DOI: 10.1111/pcmr.12484

Delic S., Thuy A., Schulze M., Proescholdt MA., Dietrich P., Boßerhoff AK., Riemenschneider MJ.:
Systematic Investigation of CMTM Family Genes Suggests Relevance to Glioblastoma Pathogenesis and CMTM1 and CMTM3 as Priority Targets
In: Genes Chromosomes & Cancer 54 (2015), p. 433-443
ISSN: 1045-2257
DOI: 10.1002/gcc.22255
Dietrich P., Boßerhoff AK.:
Modifying microRNAs--another piece of the melanoma puzzle
In: Pigment Cell & Melanoma Research 28 (2015), p. 488-9
ISSN: 1755-1471
DOI: 10.1111/pcmr.12389
Hartl J., Dietrich P., Moleda L., Mueller-Schilling M., Wiest R.:
Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension
In: Liver International 35 (2015), p. 2556-63
ISSN: 1478-3223
DOI: 10.1111/liv.12874
Ruedel A., Dietrich P., Schubert T., Hofmeister S., Hellerbrand C., Boßerhoff AK.:
Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts
In: International Journal of Clinical and Experimental Pathology 8 (2015), p. 4953-62
ISSN: 1936-2625

Dietrich P., Hellerbrand C.:
Non-alcoholic fatty liver disease, obesity and the metabolic syndrome
In: Best Practice & Research in Clinical Gastroenterology 28 (2014), p. 637-53
ISSN: 1521-6918
DOI: 10.1016/j.bpg.2014.07.008

Publikationen

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014